Guardian Pharmacy Services, Inc.
GRDNNYSEHealthcare● Active
$40.65
+$0.17(+0.41%)
Market Cap$2.6B
P/E Ratio—
52W High$41.36
52W Low$19.17
Guardian Pharmacy Services, Inc. (GRDN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GRDN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.29
Est. $0.24 · +20.8%
Revenue
$0.34B
Est. $0.33B · +2.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
GRDN reports quarterly as a NYSE-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | $0.26 | — | — | — | $0.34B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $0.24 | $0.29 | +20.8% | $0.34B | $0.33B | +2.0% |
| ▲ Q1 FY2026 | Mar 11, 2026 | $0.27 | $0.37 | +37.0% | $0.40B | $0.39B | +1.9% |
| ▲ Q4 FY2025 | Nov 10, 2025 | $0.24 | $0.25 | +4.2% | $0.38B | $0.39B | -3.2% |
| ▲ Q3 FY2025 | Aug 11, 2025 | $0.22 | $0.23 | +4.5% | $0.34B | $0.34B | +0.1% |
| ▼ Q2 FY2025 | May 12, 2025 | $0.22 | $0.21 | -4.5% | $0.33B | $0.33B | -0.0% |
| ▲ Q1 FY2025 | Mar 26, 2025 | $0.21 | $0.24 | +14.3% | $0.34B | $0.32B | +4.8% |
| ▼ Q4 FY2024 | Nov 12, 2024 | $0.19 | -$2.00 | -1152.6% | $0.31B | $0.30B | +3.7% |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
$0.26
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$0.29
EPS Est.
$0.24
EPS Surpr.
+20.8%
Revenue
$0.34B
Q1 FY2026
Mar 11, 2026Beat
EPS Actual
$0.37
EPS Est.
$0.27
EPS Surpr.
+37.0%
Revenue
$0.40B
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
$0.25
EPS Est.
$0.24
EPS Surpr.
+4.2%
Revenue
$0.38B
Q3 FY2025
Aug 11, 2025Beat
EPS Actual
$0.23
EPS Est.
$0.22
EPS Surpr.
+4.5%
Revenue
$0.34B
Q2 FY2025
May 12, 2025Miss
EPS Actual
$0.21
EPS Est.
$0.22
EPS Surpr.
-4.5%
Revenue
$0.33B
Q1 FY2025
Mar 26, 2025Beat
EPS Actual
$0.24
EPS Est.
$0.21
EPS Surpr.
+14.3%
Revenue
$0.34B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$2.00
EPS Est.
$0.19
EPS Surpr.
-1152.6%
Revenue
$0.31B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.51 | $0.52 | $0.53 | 3 |
| Q3 FY2028 | $0.38 | $0.39 | $0.39 | 2 |
| Q2 FY2028 | $0.35 | $0.36 | $0.36 | 2 |
| Q1 FY2028 | $0.34 | $0.34 | $0.34 | 3 |
| Q4 FY2027 | $0.44 | $0.45 | $0.45 | 2 |
| Q3 FY2027 | $0.33 | $0.33 | $0.34 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.4B | $0.5B | $0.5B | 2 |
| Q3 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 2 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +20.8% | $37.24 | $36.58 | -1.77% |
| ▲ Q1 FY2026 | Mar 11, 2026 | +37.0% | $33.65 | $33.51 | -0.42% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +4.2% | $28.80 | $29.75 | +3.30% |
| ▲ Q3 FY2025 | Aug 11, 2025 | +4.5% | $19.97 | $19.88 | -0.45% |
| ▼ Q2 FY2025 | May 12, 2025 | -4.5% | $25.63 | $25.66 | +0.12% |
| ▲ Q1 FY2025 | Mar 26, 2025 | +14.3% | $20.33 | $20.23 | -0.49% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -1152.6% | $22.25 | $22.18 | -0.31% |
| — Q3 FY2024 | Sep 26, 2024 | — | No price data | $16.00 | — |
Q2 FY2026-1.77%
Report Date
May 6, 2026
EPS Beat/Miss
+20.8%
Price Before
$37.24
Price After
$36.58
Q1 FY2026-0.42%
Report Date
Mar 11, 2026
EPS Beat/Miss
+37.0%
Price Before
$33.65
Price After
$33.51
Q4 FY2025+3.30%
Report Date
Nov 10, 2025
EPS Beat/Miss
+4.2%
Price Before
$28.80
Price After
$29.75
Q3 FY2025-0.45%
Report Date
Aug 11, 2025
EPS Beat/Miss
+4.5%
Price Before
$19.97
Price After
$19.88
Q2 FY2025+0.12%
Report Date
May 12, 2025
EPS Beat/Miss
-4.5%
Price Before
$25.63
Price After
$25.66
Q1 FY2025-0.49%
Report Date
Mar 26, 2025
EPS Beat/Miss
+14.3%
Price Before
$20.33
Price After
$20.23
Q4 FY2024-0.31%
Report Date
Nov 12, 2024
EPS Beat/Miss
-1152.6%
Price Before
$22.25
Price After
$22.18
Q3 FY2024—
Report Date
Sep 26, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$16.00
Avg Beat Reaction+0.03%
Avg Miss Reaction-0.10%
Beat Rate5 / 8 quarters
Largest Move+3.30% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GRDN ends December
Guardian Pharmacy Services, Inc. (GRDN) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.29 — beating the analyst consensus of $0.24 by +20.8%. GRDN has beaten EPS estimates for 4 consecutive quarters. The next GRDN earnings date is expected around September 1, 2026.
Each quarter, investors track GRDN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GRDN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GRDN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GRDN earnings · 5 questionsGuardian Pharmacy Services, Inc.'s next earnings report is expected around September 1, 2026. GRDN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GRDN historically reports after market close (AMC).
GRDN earnings datewhen is GRDN earningsGRDN next earnings datewhen does GRDN report earningsGRDN earnings calendar
▸ Source: FMP · Guardian Pharmacy Services, Inc. SEC filings · US GAAP · Guardian Pharmacy Services, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026